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Abstract
OBJECTIVE: To assess the clinical effect and safety
of direct current (DC) pulse produced by Han's Acu-
point Nerve Stimulator in reduction (HANS) of la-
bor pain.
METHODS: Totally 120 participants were enrolled
in this clinical trial, and were randomly divided into
4 groups including: HANS group, patient controlled
intravenous analgesia (PCIA) group, patient-con-
trolled epidural analgesia (PCEA) group and control
group. The HANS group was treated by stimulating
the acupoints of JiaJi (T10-L3) and Ciliao (BL 32)
with DC pulse of 100 Hz and 15-30 mA produced
by a portable battery-powered Han's Acupoint
Nerve Stimulator for 30 min. The PCIA group was in-
travenously infused Ondansetron (8 mg) for 5 min,
then tramadol injection (1.5 mg/kg) was slowly
dripped by using BaxterAPⅡ electronic pump with
50 mL tramadol (0.70% ) + ondansetron (8 mg),
background infusion 2 mL/h, PCA dose of 2 mL,
lockout interval of 10 min. In PCEA group, women
received intrathecal injection ropivacaine (3 mg) in
L2-3, and epidural catheter was connected to Bax-
terAPⅡ electronic pump, with 100 mL Ropivacaine
(0.1%) and Sufentanil (50 ug), background infusion
5 mL, Patient controlled analgesia (PCA) dose of 5
mL, lockout interval of 10 min. The control group
was not received analgesia. The visual analogue
scale (VAS), stage and manner of labor, Apgar score
of newborn, neonatal weights, oxytocin dosage,
postpartum hemorrhage and side effects were
monitored in all groups.
RESULTS: The vital signs were all stable in the four
analgesic groups. After analgesia, there was statisti-
cal difference in VAS score between HANS group
and control group, between PCEA group and the
control group, between PCIA group and control
group. The analgesic effect in the PCEA group was
significantly better than that of other two groups.
The second stage of labor in the PCEA group was
longer than the other three groups, showing signifi-
cant difference between them. The Apgar score of
newborn 1min after birth in the PCIA group was
slightly lower than that of the other two groups,
showing significant difference between them. The
neonatal weights between four groups were not
significantly different. The rate of cesarean section
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in the control group was significantly higher than
that of the labor analgesia group, there was statisti-
cally difference in four groups. The number of PCIA
group that used oxytocin was lower than that of
other three groups. There was no significant differ-
ence in postpartum hemorrhage between four
groups. The side effects of the PCEA group were
itching, uroschesis and neonatal asphyxia and PCIA
group were nausea and vomiting and neonatal as-
phyxia. However, fewer side effects were observed
in the HANS group.
CONCLUSION: The DC pulse produced by HANS
may be a non-pharmacological alternative to labor
pain with fewer side effects.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Currently the women giving birth account for 21%
married women, about 280 million in China.1 During
labor process, women will suffer severe labor pain,
which inevitably lead to tension, vascular spasm, unco-
ordinated contraction of the uterus. If serious, it will al-
so cause severe fetal hypoxia, blocked stage of labor
and even threaten maternal and child safety.
Labor analgesia could not only relieve labor pains, but
also improve the maternal and child health and de-
crease the cesarean section rate.2 In 1847, a British ob-
stetrician, Tames Simpson, firstly used Ether in labor
analgesia. Since then, people continually investigated
how to make a woman safely give birth in a sober,
no-pain state.3 Presently, there are two types of labor an-
algesia methods: non-drug analgesia and drug-induced
analgesia. The non-drug analgesia mainly includes the
mental prevention analgesia, Lamaze's method, accom-
panying labor, acupuncture analgesia, transcutaneous
electrical stimulation analgesia.4 The drug-induced an-
algesia contains Opioids, Tramadol hydrochloride and
Pethidine. Although narcotic analgesic are commonly
used in clinics, their applicaition are also limited be-
cause of contraindications and side effects.5 Many stud-
ies demonstrated that Han's Acupoint Nerve Stimula-
tor can decrease labor pain during the labor process by
peripheral electrical stimulation, which might lead to
release of opioid peptides in central nervous system.6Al-
though Han's Acupoint Nerve Stimulator was effective
for labor relief, the study to compare its effectiveness
with other methods was seldom reported.
In this study, we aimed to evaluate the effect and safety
of direct current (DC) pulse generated by Han's acu-
point nerve stimulator (HANS) to reduce labor pain.
MATERIALS ANDMETHODS
Subjects
Our study recruited participants between August 2010
and November 2013. Totally 120 participants were en-
rolled in this clinical trial. They were from Beijing Ob-
stetrics and Gynecology Hospital. The age was 20-29
year old. The study was approved by the research ethics
committee of the Beijing Obstetrics and Gynecology
Hospital. After an explanation of the study procedures,
each participant signed informed consent form. Active
phase was confirmed and diameters of cervical dilata-
tion were determined by the obstetrical personnel.
Inclusion criteria
The inclusion criteria were: (a) no previous poor obstet-
rical outcome; (b) no experience in Han's Acupoint
Nerve Stimulator and TENS for other reasons; (c)
term pregnancy (> 37 weeks of gestation); (d) at active
phase of the first stage of labor with cervical dilatation
3 cm.
Exclusion criteria
Patients were excluded if they: (a) had the history of ex-
perimental drug allergy; (b) had been diagnosed with
other diseases such as preoperative presence of mater-
nal mental, neurological diseases, affecting evaluation
of pains and disease conditions; (c) had combined with
gestational hypertension, gestational diabetes, gestation-
al thyroid diseases; (d) had taken analgesic drugs or
with a history of long-term use of analgesic drugs; (e)
had used diazepam, piperazine hydrochloride or other
sedative, analgesic drugs in the stages of labor; (f ) were
overweight or low pregnancy weight,body mass index
(BMI)< 18.5 or BMI > 25 kg/m2; (g) were not agree to
receive painless labor and not sign the informed con-
sent from.
Treatment
The control group was not received analgesia. The
HANS group received DC pulse stimulus at acupounts
of Jiaji points (T 10-L 3) and Ciliao (BL 32)The stimu-
lus was 100 Hz with a burst frequency of 2 Hz (dense-
dispersed waveform) The intensity was 15-30 mA. The
pulse duration was used for 30 min. Women in the
PCIA group were intravenously infused ondansetron
8 mg; 5 min later, 1.5 mg/kg tramadol injection was
slowly dripped, connected to Baxter APⅡ electronic
pump with 50 mL of 0.70% tramadol + ondanse-
tron 8 mg, background infusion 2 mL/h, PCA dose of
2 mL, lockout interval of 10 min. patient-controlled
epidural analgesia (PCEA) group: L2-3 combined spi-
nal-epidural puncture, intrathecal injection of 3mg rop-
ivacaine, epidural catheter connected to BaxterAPⅡ
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electronic pump, with 100 mL 0.1% ropivacaine and
50 ug sufentanil, background infusion 5 mL, PCA
dose of 5 mL, lockout interval of 10 min when the cer-
vix was fully dilated (10 cm). All treatments were
stopped at the point of complete cervical dilatation.
Outcome measures
The basic vital signs of the parturient (blood pressure,
electrocardiograph, oxygen saturation, respiration)
were measured. The pain intensity was measured with
visual analogue scale (VAS): from 1 (no pain) to 10
(the most painful). Participants were asked by study
personnel to estimate how painful during the last con-
traction before the application of analgesia. The VAS
was recorded at each application (30 and 60 min after
analgesia, cervical dilatation to 7-8 cm, the end of the
first stage). The labor time, labor mode, delivery rate,
oxytocin dosage, postpartum hemorrhage side effects
were observed. The birth-weight was recorded after de-
livery. Neonatal assessments were Apgar score at 1 and
5 min after birth.
Statistical analysis
All the outcomes were expressed as mean ± standard de-
viation ( xˉ ± s). Statistical analysis was undertaken us-
ing SPSS version 16.0 (International Business Ma-
chines Corporation, Armonk, NY, USA). Data among
groups were compared using analysis of variance; (b)
comparison of categorical data among four groups
were analyzed by Chi-square test; (c) repeated measures
analysis of variance were employed to analyze repeated
measurement data; (d) least significant difference-t test
was performed for comparison between groups. P <
0.05 was the significant level.
RESULTS
After enrollment, 120 participants were randomized in-
to four groups according to a random number table
method. There was no statistical difference in the basic
information between four groups (P > 0.05, Table 1,
Figure 1).
The vital signs were all stable in the three analgesic
groups. The blood pressure of the parturient in the
PCEA group 5 min and 15 min after analgesia were
110.5 ± 9.2 / 65.3 ± 4.2 mm Hg, and 112.1 ± 8.5 /
64.7 ± 5.6 mm Hg respectively, and the SBP and DBP
decreased slightly, showing significant difference com-
pared with those before analgesia (P < 0.05), In the
PCIA group, the blood pressure decreased slightly at
15 min, showing no statistically significant difference
(P > 0.05).
There was no significant difference in VAS score of the
four groups of the parturient before analgesia (P >
0.05). After analgesia, there was statistical difference in
VAS score between HANS group and control group
(P < 0.05), between PCEA group and control group,
between PCIA group and control group (P < 0.05).
The analgesic effect in the PCEA group was significant-
ly better than that of other two groups (Table 2).
The second stage of labor in the PCEA group was lon-
ger than the other three groups, showing significant dif-
ference between them. The Apgar score of newborn
1min after birth in the PCIA group was slightly lower
than that of the other three groups, showing significant
difference between them. The neonatal weights be-
tween four groups were not significantly different (P >
0.05, Table 3).
The rate of cesarean section in the control group was
significantly higher than that of the labor analgesia
group, There was statistically difference in four groups
(P < 0.01).The number of PCIA group that used oxy-
tocin was lower than that of other three groups (P <
0.05).There was no significant difference in postpartum
hemorrhage between four groups (P > 0.05, Table 4).
Evaluated whether entry the study
according to standard of inclusion
Randomization
(n = 120)
HANS group
(n = 40)
PCIA group
(n = 40)
PCEA group
(n = 40)
Control group
(n = 40)
Analyze
inclusion
(n = 40)
Analyze
inclusion
(n = 40)
Analyze
inclusion
(n = 40)
Analyze
inclusion
(n = 40)
Figure 1 Flow diagram of the study
Group
HANS
PCIA
PCEA
Control
n
30
30
30
30
Age (years)
27.5±3.8
28.3±4.0
28.0±4.1
26.6±3.8
Gestational age (weeks)
39.0±0.7
39.1±0.8
39.3±0.8
39.0±0.8
Body height (cm)
163.5±5.6
161.2±5.4
163.0±5.6
162.7±5.6
Weight (kg)
71.1±9.9
72.1±10.3
71.7±10.3
72.1±10.3
Diameter of cervical (cm)
3.2±0.4
3.2±0.4
3.3±0.4
3.3±0.4
Notes: HANS: the Han's acupoint nerve stimulator group; PCIA: patient-controlled intravenous analgesia group; PCEA: patient-con-
trolled epidural analgesia group. Patients in the HANS group were treated with Han's acupoint nerve stimulator; patients in the PCIA
group were treated with patient-controlled intravenous analgesia; patients in the PCEA group were treated with patient-controlled epidural
analgesia; patients in the control group were not received analgesia.
Table 1 Parturient characteristics ( xˉ ± s)
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The side effects in the HANS group were neonatal as-
phyxia, and the complication rate was 6.67%. Side ef-
fects in the PCIA group were nausea and vomiting and
neonatal asphyxia, while side effects in the PCEA
group were itching, uroschesis and neonatal asphyxia.
There were 2 cases of neonatal asphyxia in control
group. There was significant difference in four groups
(P < 0.05, Table 5).
DISCUSSION
Pregnancy and delivery is an important component of
reproductive health. Over 90% of the parturient may
have a strong anxiety, tension and even fear due to the
severe labor pain.7
These negative stress may cause a series of neuroendo-
crine reactions, and lead to various functional and met-
abolic changes, such as increased heart rate, elevated
blood pressure, hyperventilation and increased oxygen
consumption.8,9 The raise of cesarean section rate will
lead to high risk of the surgical complications to the
mother and child.10 Therefore, creating a safe and pain-
less delivery environment from the obstetric mode of
'improving quality of perinatal infant and implement-
ing people-oriented' is an important research content
of the perinatal medicine.11
In 1847, a British obstetrician, Tames Simpson, suc-
cessfully completed the first case of labor analgesia op-
eration in the world. After that, people has been devel-
oping a safe analgesic technique for years.12 An ideal la-
bor analgesia should have the following characteristics:
(a): safety for mother and child; (b): rapid onset of
drug administration, reliable action, to meet the need
of the whole duration of labor; (c): avoid movement re-
Notes: HANS: the Han's acupoint nerve stimulator group; PCIA: patient-controlled intravenous analgesia group; PCEA: patient-con-
trolled epidural analgesia group. Patients in the HANS group were treated with Han's acupoint nerve stimulator; patients in the PCIA
group were treated with patient-controlled intravenous analgesia; patients in the PCEA group were treated with patient-controlled epidural
analgesia; patients in the control group were not received analgesia. Compared with control group, aP < 0.05; compared with HANS
group, bP < 0.05; compared with PCIA group, cP < 0.05.
Group
HANS
PCIA
PCEA
control
n
30
30
30
30
Before analgesia
95±12a
94±10a
95±10a
94±11
30 min after
71±13a
51±11ab
18±5abc
97±13
60 min after
65±12a
45±8ab
20±6abc
97±14
Cer 7-8 cm
68±11a
50±11ab
24±4abc
98±14
Cer 10 cm
60±13a
50±12ab
27±5abc
90±15
Table 2 Comparison of VAS in four groups ( xˉ ± s)
Notes: HANS: the Han's acupoint nerve stimulator group; PCIA: patient-controlled intravenous analgesia group; PCEA: patient-con-
trolled epidural analgesia group. Patients in the HANS group were treated with Han's acupoint nerve stimulator; patients in the PCIA
group were treated with patient-controlled intravenous analgesia; patients in the PCEA group were treated with patient-controlled epidural
analgesia; patients in the control group were not received analgesia. Compared with PCEA group, aP < 0.05; compared with PCIA group,
bP < 0.05.
Group
HANS
PCIA
PCEA
Control
n
30
30
30
30
Stag of labor (min)
First
430.1±119.8
425.2±198.7
423.3±181.2
439.6±200.3
Second
43.3±17.5a
45.9±22.5a
61.2±29.4
46.3±20.6a
Third
8.9±3.1
9.1±3.1
9.4±4.2
9.3±3.0
Apgar score
9.9±0.7 b
9.2±0.3
9.8±0.5 b
9.9±0.9 b
1 min 5 min
9.9±0.9
9.8±0.8
9.9±0.7
9.9±0.8
Neonatal weight
(g)
3301.3±321.8
3275.5±263.3
3205.5±434.4
3311.2±392.1
Table 3 Comparison of stage of labor, neonatal weight and Apgar score between four groups ( xˉ ± s)
Group
HANS
PCIA
PCEA
Control
n
30
30
30
30
Natural labor
27a
26a
26a
20
Instrumental delivery
(n)
2
2
2
2
Cesarean section
(n)
1a
2a
2a
8
Use of oxytocin
(n)
12 b
6
13 b
14 b
Postpartum hemorrhage
(mL)
126.5±22.9
132.5±25.4
124.7±23.7
139.8±29.0
Notes: HANS: the Han's acupoint nerve stimulator group; PCIA: patient-controlled intravenous analgesia group; PCEA: patient-con-
trolled epidural analgesia group. Patients in the HANS group were treated with Han's acupoint nerve stimulator; patients in the PCIA
group were treated with patient-controlled intravenous analgesia; patients in the PCEA group were treated with patient-controlled epidural
analgesia; patients in the control group were not received analgesia. Compared with control group, aP < 0.05; compared with PCIA group,
bP < 0.05.
Table 4 Comparison of delivery mode and use of oxytocin between four groups
623
JTCM |www. journaltcm. com December 15, 2015 |Volume 35 | Issue 6 |
Liu Y et al. / Clinical Study
tardation, not affecting actions of the parturient's
movements; (d): the parturient were sober in the whole
delivery process; (e): meet the demand of surgery when
necessary. Currently the popular analgesia method is
patient-controlled epidural analgesia because of simple
epidural analgesia, combined spinal and epidural block
analgesia, continuous spinal anesthesia.13 Presently, the
spinal combing with epidural analgesia is the widely
used.14 The main drugs used in patient-controlled epi-
dural analgesia are ropivacaine and opioids (sufentanil,
fentanyl). The main pharmacological properties of ropi-
vacaine is apparent separation of sensory and motor
nerve blockade, especially the blocking and separating
properties at a low-dose and low concentration. How-
ever, with the continuous development of new technol-
ogies, Spinocath catheter emerged, which could be
used to continuous spinal analgesia with less invasion.15
Zhang Ning et al. performed the labor analgesia at the
latent period through continuous intrathecal injection,
with the analgesia recipe of sufentanil 1 μg/mL. Com-
pared with combined spinal and epidural analgesia
group, there was no significant differences in labor du-
ration, natural birth rate, analgesic satisfaction rate,
and side effects such as itching, post-dural puncture
headache between them., thus, the effect of labor anal-
gesia by continuous intrathecal injection method was
similar to that of combined spinal epidural analgesia.16
However, since PCEA had the characteristics of compli-
cated operation, high requirements for operators and
the parturient, it is not suitable for all the parturient.
The reasons are following (a): PCEA is an invasive pro-
cedure, having such complications as intraspinal hema-
toma, abscess, spinal nerve injury, headache and waist
and back pains after puncture, etc; (b): rapid duration
of labor, missing the opportunity of epidural puncture;
(c): parturient's fear of epidural puncture; (d): not suit-
able for epidural puncture (intraspinal diseases such as
lumbar intervertebral disc herniation, history of lum-
bar spine surgery, back infection, blood clotting abnor-
malities, etc.; (e): puncture operation fails due to mater-
nal obesity, etc.17
HANS has been used in China for more than 20 years.
The use of HANS was introduced in 2002 as an effec-
tive approach for pain relief for the women in labor.18
Traditionally, two pairs of electrodes are placed along-
side the spine. These segments corresponded to the
pathways of A ﬁbres into the inhibitory circuits in the
laminae of the dorsal horn of spinal cord. It concluded
that high freguency (100 Hz) transcuraneous electric
nerve stimulation can improve naloxone reversible and
low frequency (2 Hz) improve the lever of endorphin
and enkephalin in vivo. The frequency conversion can
raise three alleviations in vivo. However, It can increas-
es pain threshold by regulating the content of β-endor-
phin level in peripheral blood of the parturient.19
The HANS, Patient-controlled intravenous analgesia
(PCIA) and PCEA are widely used in the treatment of
labor pain. In this study, we aimed to observe therapeu-
tic effects of three methods. However, no studies are re-
ported. So we designed 4 groups to perform a random-
ized, control trial including HANS, PCIA, PCEA and
control group The results indicated that the four
groups were well matched in terms of mean pain inten-
sity, but the VAS scores at 30, 60 min, cervical dilation
7-8 cm and 10 cm time points after treatment had ex-
tremely significant differences compared with that of
control group (P < 0.05).VAS scores in PCEA group at
each time point after beginning of treatment were low-
er than those in PCIA and HANS group (P < 0.05).
At the same time, the mean VAS scores in HANS were
all lower than that in the control group (P < 0.05).
Limitations of this study include its small size, the lack
of fetal blood gas analysis, and uterine contraction. Fur-
ther study should be conducted to investigated the ef-
fect of HANS plus h PCEA for labor analgesia. In con-
clusion, HANS can be a non-pharmacological analge-
sic therapy for labor pain with fewer side effects.
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